-
Hepatocellular carcinoma (HCC) is the most
common type of
primary liver cancer in
adults and is
currently the most
common cause of
death in
people with...
-
Hepatocellular adenoma (also
known as
hepatic adenoma or hepadenoma) is a rare,
benign liver tumor. It most
commonly occurs in
people with
elevated systemic...
-
including Asia and sub-Saharan Africa.
Males are more
often affected with
hepatocellular carcinoma (HCC) than females.
Diagnosis is most
frequent among those...
- common. FLC, also
known as
fibrolamellar hepatocellular carcinoma, is
different from the more
common hepatocellular carcinoma (HCC) in that it
afflicts young...
-
cancer (advanced
renal cell carcinoma),
advanced primary liver cancer (
hepatocellular carcinoma), FLT3-ITD
positive AML and
radioactive iodine resistant advanced...
-
approves tremelimumab in
combination with
durvalumab for
unresectable hepatocellular carcinoma". Food and Drug Administration.
Retrieved 2023-05-22. FDA :...
-
longer period of time. Park et al.
conceptualized carcinogenesis of
hepatocellular carcinoma (HCC) as a
multistep process involving parenchymal arterialization...
-
categorize benign liver tumors is by
their anatomic source, such as
hepatocellular, biliary, or stromal.: 693–704
Cavernous hemangiomas (also
called hepatic...
-
vitamin K. A 1984
study first described the use of DCP as a
marker of
hepatocellular carcinoma (HCC); it was
present in 91% of HCC patients,
while not being...
-
medication used to
treat medullary thyroid cancer,
renal cell carcinoma, and
hepatocellular carcinoma. It is a small-molecule tyrosine-kinase
inhibitor (TKI) of...
